SCHEMBL29796857

SCHEMBL29796857

CC(C)(C)OC(=O)N[C@H]1CSc2cc(F)c(-c3nnc(C(C)(C)C)o3)cc2N(Cc2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 3/20 0.36
▸ GRM2 Q14416 2/20 0.33
▸ CHRM5 P08912 3/20 0.32
▸ PLAT P00750 1/20 0.32
▸ GCGR P47871 1/20 0.32
▸ GIPR P48546 1/20 0.32
▸ TEAD1 P28347 1/20 0.32
▸ CTSL P07711 1/20 0.31
▸ CTSB P07858 1/20 0.31
▸ CTSS P25774 1/20 0.31
▸ CTSK P43235 1/20 0.31
▸ NPY1R P25929 1/20 0.31
▸ XIAP P98170 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ PTGDR2 Q9Y5Y4 1/20 0.31
▸ SCN9A Q15858 1/20 0.31
▸ HCRTR1 O43613 1/20 0.31
▸ HCRTR2 O43614 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26961825 1.00 SRC (0.36) SRCGRM2CHRM5PLATGCGR
SCHEMBL29796777 0.93 SRC (0.35) SRCGRM2
SCHEMBL26961736 0.93 SRC (0.35) SRCGRM2
SCHEMBL26961878 0.92 POLB (0.35) SRCNPY1RXIAP
SCHEMBL29796826 0.92 POLB (0.35) SRCNPY1RXIAP
SCHEMBL26961887 0.90 SRC (0.39) SRCGRM2NPY1RCACNA1H
SCHEMBL29796737 0.90 SRC (0.39) SRCGRM2NPY1RCACNA1H
SCHEMBL26962177 0.89 SRC (0.38) SRCGRM2CHRM5GCGRGIPR
SCHEMBL29796984 0.89 SRC (0.38) SRCGRM2CHRM5GCGRGIPR
SCHEMBL30767410 0.86 GRM2 (0.34) GRM2CHRM5PLATGCGRGIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP disclosed
WO-2022171745-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2022-08-18 — — WO disclosed
Send feedback